Regional differences in five-year mortality after a first episode of schizophrenia in Finland

Psychiatric Services

Volumn 61, Issue 3, 2010, Pages 272-279

  Kiviniemi, Marjo ^a,b   Suvisaari, Jaana ^c   Pirkola, Sami ^d   Häkkinen, Unto ^c   Isohanni, Matti ^a,e   Hakko, Helinä ^a,e  

^a UNIVERSITY OF OULU   (Finland)

^b Social and Mental Health Services   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DEMOGRAPHY; ETHNIC AND RACIAL GROUPS; FEMALE; FINLAND; FOLLOW UP; GROUPS BY AGE; HEALTH CARE PLANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; POPULATION; REGIONAL DIFFERENCE; SCHIZOPHRENIA; STANDARDIZED MORTALITY RATIO; SUICIDE;

EID: 77949356481     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2010.61.3.272     Document Type: Article

References (60)

1. Hennekens CH, Hennekens AR, Hollar D, et al: Schizophrenia and increased risks of cardiovascular disease. American Heart Journal 150:1115-1121, 2005
2. Brown S, Inskip H, Barraclough B: Causes of the excess mortality of schizophrenia. British Journal of Psychiatry 177:212-217, 2000
3. Saha S, Chant D, McGrath J: A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Archives of General Psychiatry 64:1123-1131, 2007
4. Brown S: Excess mortality of schizophrenia: a meta-analysis. British Journal of Psychiatry 171:502-508, 1997
5. Harris EC, Barraclough B: Excess mortality of mental disorder. British Journal of Psychiatry 173:11-53, 1998
6. Palmer BA, Pankratz VS, Bostwick JM: The lifetime risk of suicide in schizophrenia: a reexamination. Archives of General Psychiatry 62:247-253, 2005
7. Qin P, Nordentoft M: Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers. Archives of General Psychiatry 62:427-432, 2005
8. Nordentoft M, Laursen TM, Agerbo E, et al: Change in suicide rates for patients with schizophrenia in Denmark, 1981-97: nested case-control study. British Medical Journal 329:261, 2004
9. Bertelsen M, Jeppesen P, Petersen L, et al: Suicidal behaviour and mortality in first-episode psychosis: the OPUS trial. British Journal of Psychiatry Supplement 51:s140-s146, 2007
10. Goff DC, Cather C, Evins AE, et al: Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. Journal of Clinical Psychiatry 66:183-194, 2005
11. Sernyak MJ, Leslie DL, Alarcon RD, et al: Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. American Journal of Psychiatry 159:561-566, 2002
12. Koponen H, Saari K, Savolainen M, et al: Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication: a review. European Archives of Psychiatry and Clinical Neuroscience 252:294-298, 2002
13. Volavka J, Czobor P, Sheitman B, et al: Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. American Journal of Psychiatry 159:255-262, 2002
14. Green AI, Patel JK, Goisman RM, et al: Weight gain from novel antipsychotic drugs: need for action. General Hospital Psychiatry 22:224-235, 2000
15. Koponen H, Alaräisänen A, Saari K, et al: Schizophrenia and sudden cardiac death: a review. Nordic Journal of Psychiatry 62:342-345, 2008
16. Hennessy S, Bilker WB, Knauss JS, et al: Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. British Medical Journal 325:1070, 2002
17. Daumit GL, Goff DC, Meyer JM, et al: Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophrenia Research 105:175-187, 2008
18. Druss BG, Bradford DW, Rosenheck RA, et al: Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 283:506-511, 2000
19. Druss BG, Bradford WD, Rosenheck RA, et al: Quality of medical care and excess mortality in older patients with mental disorders. Archives of General Psychiatry 58:565-572, 2001
20. Lawrence DM, Holman CD, Jablensky AV, et al: Death rate from ischaemic heart disease in western Australian psychiatric patients 1980-1998. British Journal of Psychiatry 182:31-36, 2003
21. Ringbäck Weitoft G, Gullberg A, Rosen M: Avoidable mortality among psychiatric patients. Social Psychiatry and Psychiatric Epidemiology 33:430-437, 1998
22. Ösby U, Correia N, Brandt L, et al: Mortality and causes of death in schizophrenia in Stockholm County, Sweden. Schizophrenia Research 45:21-28, 2000
23. Papastergiou P, Rachiotis G, Polyzou K, et al: Regional differences in mortality in Greece (1984-2004): the case of Thrace. BMC Public Health 8:297, 2008
24. Saarela J, Finnäs F: Cause-specific mortality at young ages: lessons from Finland. Health Place 14:265-274, 2008
25. Lewis G, Booth M: Regional differences in mental health in Great Britain. Journal of Epidemiology and Community Health 46:608-611, 1992
26. Karvonen M, Peltola M, Isohanni M, et al: PERFECT-schitzophrenia: PERFormance, Effectiveness, and Cost of Treatment [in Finnish]. Helsinki, Finland, Stakes, 2008
27. Salokangas RK, Helminen M, Koivisto A, et al: Mortality of patients with schizophrenia in health care districts [in Finnish]. Suomen Lääkä rilehti 63:3759-3766, 2008
28. Pihlajamaa J, Suvisaari J, Henriksson M, et al: The validity of schizophrenia diagnosis in the Finnish hospital discharge register: findings from a 10-year birth cohort sample. Nordic Journal of Psychiatry 62:198-203, 2008
29. Moilanen K, Veijola J, Läksy K, et al: Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the northern Finland 1966 birth cohort. Social Psychiatry and Psychiatric Epidemiology 38:305-310, 2003
30. Isohanni M, Mäkikyrö T, Moring J, et al: A comparison of clinical and research DSMIII-R diagnoses of schizophrenia in a Finnish national birth cohort: clinical and research diagnoses of schizophrenia. Social Psychiatry and Psychiatric Epidemiology 32:303-308, 1997
31. Lahti RA, Penttilä A: The validity of death certificates: routine validation of death certification and its effects on mortality statistics. Forensic Science International 115:15-32, 2001
32. Mortensen PB, Juel K: Mortality and causes of death in first admitted schizophrenic patients. British Journal of Psychiatry 163:183-189, 1993
33. Heilä H, Haukka J, Suvisaari J, et al: Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychological Medicine 35:725-732, 2005
34. Laursen TM, Munk-Olsen T, Nordentoft M, et al: Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. Journal of Clinical Psychiatry 68:899-907, 2007
35. Black DW: Mortality in schizophrenia-the Iowa record-linkage study: a comparison with general population mortality. Psychosomatics 29:55-60, 1988
36. Salokangas RK, Honkonen T, Stengard E, et al: Mortality in chronic schizophrenia during decreasing number of psychiatric beds in Finland. Schizophrenia Research 54:265-275, 2002
37. Räsänen S, Hakko H, Viilo K, et al: Excess mortality among long-stay psychiatric inpatients in northern Finland: a challenge for health care. Duodecim 120:179-180, 2004
38. Joukamaa M, Heliovaara M, Knekt P, et al: Mental disorders and cause-specific mortality. British Journal of Psychiatry 179:498-502, 2001
39. Brown S, Birtwistle J, Roe L, et al: The unhealthy lifestyle of people with schizophrenia. Psychological Medicine 29:697-701, 1999
40. Lund BC, Perry PJ, Brooks JM, et al: Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach. Archives of General Psychiatry 58:1172-1176, 2001
41. Reist C, Mintz J, Albers LJ, et al: Second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia: an observational pharmacoepidemiology study from 1988 to 2002. Journal of Clinical Psychopharmacology 27:46-51, 2007
42. Ray WA, Meredith S, Thapa PB, et al: Antipsychotics and the risk of sudden cardiac death. Archives of General Psychiatry 58:1161-1167, 2001
43. Nasrallah HA, Meyer JM, Goff DC, et al: Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research 86:15-22, 2006
44. Conley RR, Ascher-Svanum H, Zhu B, et al: The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophrenia Research 90:186-197, 2007
45. Murray GK, Jones PB, Moilanen K, et al: Infant motor development and adult cognitive functions in schizophrenia. Schizophrenia Research 81:65-74, 2006
46. Allebeck P, Wistedt B: Mortality in schizophrenia: a ten-year follow-up based on the Stockholm County Inpatient Register. Archives of General Psychiatry 43:650-653, 1986
47. Jääskeläinen A: Autopsy in forensic medicine and the protection of law. Duodecim 119:1265-1272, 2003
48. Nilsson LL, Logdberg B: Dead and forgotten: postmortem time before discovery as indicator of social isolation and inadequate mental healthcare in schizophrenia. Schizophrenia Research 102:337-339, 2008
49. Limosin F, Loze JY, Philippe A, et al: Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patients. Schizophrenia Research 94:23-28, 2007
50. Marlow AK: Potential years of life lost: what is the denominator? Journal of Epidemiology and Community Health 49:320-322, 1995
51. Goff DC, Sullivan LM, McEvoy JP, et al: A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Research 80:45-53, 2005
52. Bottlender R, Strauss A, Moller HJ: Impact of duration of symptoms prior to first hospitalization on acute outcome in 998 schizophrenic patients. Schizophrenia Research 44:145-150, 2000
53. Bottlender R, Sato T, Jager M, et al: The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophrenia Research 62:37-44, 2003
54. Fennig S, Rabinowitz J, Fennig S: Involuntary first admission of patients with schizophrenia as a predictor of future admissions. Psychiatric Services 50:1049-1052, 1999
55. Maurer K, Hafner H: Methodological aspects of onset assessment in schizophrenia. Schizophrenia Research 15:265-276, 1995
56. Harris DE, Aboueissa AM, Hartley D: Myocardial infarction and heart failure hospitalization rates in Maine, USA: variability along the urban-rural continuum. Rural and Remote Health 8:980, 2008
57. Lynch JW, Kaplan GA, Cohen RD, et al: Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? American Journal of Epidemiology 144:934-942, 1996
58. Petrelli A, Gnavi R, Marinacci C, et al: Socioeconomic inequalities in coronary heart disease in Italy: a multilevel population-based study. Social Science and Medicine 63:446-456, 2006
59. Poikolainen K: Accuracy of hospital discharge data: five alcohol-related diseases. Drug and Alcohol Dependence 12:315-322, 1983
60. Gissler M, Haukka J: Finnish health and social welfare registers in epidemiological research [in Finnish]. Norsk Epidemiologi 14:113-120, 2004